The more discrepant values are those of Mazal et al. as they only reported Pax-2 positivity in 14% of oncocytomas, against 87–100% of positivity in our study and those of Memeo et al. and Gupta et al. [17, 19, 23]. The gene discussed is PAX2; the disease is oncocytic adenoma.